Facebook
Twitter
LinkedIn
ForwardChemotherapy Administration - May 2022
Target Audience
Registered Nurses
Learning Objectives
Nursing Learning Outcome:
Nurses attending this program will be prepared to provide high quality evidence-based care related to anticipating the needs of patients receiving medications for chemotherapy, reducing or preventing complications from side effects and adverse drug events, and administering chemotherapeutic agents safely
Chemotherapy Administration
May 18, 2022
Time | Topic | Presenter |
0800 - 0900 | Basics of Chemotherapy | LaTarvia Moore |
0900 - 1030 | Chemotherapy Drug Overview | Cindy Lopez |
1030 - 1100 | Induction vs consolidation | Cindy Lopez |
1100 - 1200 | BMT, SQ Chemo, Targeted agents & Immunotherapy | LaTarvia Moore |
1300 -1430 | Administration Safe Practice Considerations | LaTarvia, Cindy |
1430 - 1530 | Epic Play: Treatment plans, Case study | LaTarvia, Cindy |
LaTarvia Moore, MSN, OCN, BMTCN
Cindy López, MSN, RN, OCN
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
To be awarded 7.25 continuing professional development hours, the participant must attend the program in its entirety and complete the evaluation tool.
Available Credit
- 7.25 Attendance
- 7.25 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 7.25 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.